Clinical Trials on Moderate to Severe Hearing Loss in Austria

Total 122 results

Humanigen, Inc.

Completed

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids (KB003-04)

Moderate-to-Severe Asthma

France, United Kingdom, United States, Australia, Poland, Ukraine
The Bionics Institute of Australia

Recruiting

Improving Early Intervention in Hearing Impaired Children Using Functional Near-Infrared Spectroscopy (fNIRS)

Hearing Impairment

Australia
Cochlear
Avania

Completed

Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients (POLAR) (POLAR)

Hearing Impairment

Australia
The Bionics Institute of Australia

Not yet recruiting

EarGenie MVP Performance Evaluation

Hearing Impaired Children

Australia
Sensorion

Completed

Evaluation of the Presence of SENS-401 in the Perilymph

Hearing Loss

Australia
Sonova AG

Completed

Hearing Aid Transmitter Performance Study - SRF-366

Hearing Loss

Australia
The Hearing Cooperative Research Centre
St Vincent's Hospital Melbourne; Royal Victoria Eye and Ear Hospital; Cochlear; Royal Prince Alfred Hospital, Sydney, Australia and other collaborators

Completed

Cochlear Implant With Anti-Inflammatory Agent

Hearing Loss

Australia
Frequency Therapeutics

Completed

First in Human Safety Study of FX-322 in Adults Undergoing Cochlear Implantation

Hearing Loss

Australia
Cochlear

Recruiting

New Algorithms to Signal Processing for Speech Enhancement in Adult Cochlear Implant Recipients. (PRESENCE-MU)

Hearing Loss

Australia
Amgen

Terminated

Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab (ROCkIES)

Moderate to Severe Rheumatoid Arthritis

United States, Canada, Puerto Rico
The Hearing Cooperative Research Centre
Royal Victoria Eye and Ear Hospital; Cochlear

Completed

Clinical Metrics for Assessing Cochlear Implant Recipient MAPs

Hearing Loss

Australia
The Hearing Cooperative Research Centre
Royal Victoria Eye and Ear Hospital; Cochlear

Completed

Cochlear Implant Low Power Strategy

Hearing Loss

Australia
Sonova AG
Sonova Audiological Care Australia Pty Ltd

Completed

Evaluation of Software for Self-Fitting of Hearing Aids by People With Hearing Loss

Hearing Loss

Australia
The Hearing Cooperative Research Centre
Cochlear; Attune Hearing; Sydney Cochlear Implant Clinic

Completed

Outcome Prediction in Cochlear Implant Recipients

Hearing Loss

Australia
Bristol-Myers Squibb
Nitto Denko Corporation

Completed

Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)

Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4)

Bulgaria, United States
Incyte Corporation

Recruiting

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Moderate to Severe Asthma

Korea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
Cochlear
The Hearing Cooperative Research Centre; Royal Victoria Eye and Ear Hospital

Completed

Intracochlear Potentials: Volta Study (CLTD5663)

Hearing Loss

Australia
Cochlear
The Hearing Cooperative Research Centre; The Shepherd Centre

Completed

FLI Normative Study (FLI-P)

Hearing Loss

Australia
Cochlear
The Hearing Cooperative Research Centre; Royal Victoria Eye and Ear Hospital

Completed

CHANGE Feasibility Study (CLTD5626)

Hearing Loss

Australia
Cochlear

Completed

Clinical Evaluation of Bass and Treble Controls for CI Subjects (CLASS)

Hearing Loss

Australia
Cochlear
Statistiska Konsultgruppen

Completed

Clinical Performance, Safety and Patient Reported Outcomes of an Active Osseointegrated Steady-State Implant System

Hearing Loss

Australia, Hong Kong
Cochlear

Recruiting

A Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation in Adult Cochlear Implant Recipients (FOCUS)

Hearing Impairment

Australia
The Hearing Cooperative Research Centre
Royal Victoria Eye and Ear Hospital; Cochlear; University of Melbourne

Terminated

Optimisation of Hybrid Fittings for Cochlear Implant Recipients

Hearing Loss

Australia
Hoffmann-La Roche
Pfizer

Completed

A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis

Moderate to Severe Ulcerative Colitis

United States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
Cochlear

Completed

CLEAR Clinical Study

Hearing Loss

Australia
Cochlear
Avania

Recruiting

A Study Evaluating the Application of Hearing Aid Technologies to Signal Processing for Adult Cochlear Implant Recipients (HATSI-MB)

Hearing Loss

Australia
Cochlear

Completed

Innovations in Clinical Care of CE Approved Nucleus Cochlear Implant Recipients

Hearing Loss

Belgium, Australia
University Hospital, Antwerp
Wuerzburg University Hospital; Hospital Universitario La Paz; Fiona Stanley Hospital and other collaborators

Completed

Evaluating the Revised WORQ in CI Users

Hearing Loss

Spain, Belgium, Australia, Germany, Poland
Pediatrix

Completed

Determine the Incidence of Long QT Amongst a Large Cohort of Subjects Diagnosed With Unilateral or Bilateral Sensorineural Hearing Loss.

Sensorineural Hearing Loss | Long QT Syndrome

United States
Cochlear

Recruiting

An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App (VALDE-MU)

Hearing Loss

Australia, United States, Belgium
Cochlear
Avania; Trium Clinical Consulting

Completed

Sound Processing. ( A Feasibility, Prospective, Repeated-measures Investigation to Investigate Innovations in Sound Processing in Adult and Paediatric Recipients Implanted With CE Approved Nucleus Cochlear Implants: an Umbrella Investigation)

Hearing Loss

Belgium, Australia
University Hospital, Antwerp
Wuerzburg University Hospital; Hospital Universitario La Paz; Fiona Stanley Hospital and other collaborators

Recruiting

ICF in Cochlear Implant Users

Hearing Loss

Spain, Australia, Belgium, Germany, Poland
Cochlear
Statistiska Konsultgruppen

Completed

Long Term Clinical Investigation to Evaluate Clinical Performance, Safety and Patient Reported Outcomes of an Active Osseointegrated Steady-State Implant System

Hearing Loss

Hong Kong, Australia
Qurient Co., Ltd.

Completed

Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients

Moderate to Severe Atopic Dermatitis

United States
Merz North America, Inc.
Ulthera, Inc

Completed

Open-label, Prospective Evaluation of the Ulthera® System for Lifting Submental (Under the Chin) and Neck Tissue in Chinese Patients (ULT-302)

Mild to Moderate Skin Laxity Under the Chin | Mild to Moderate Skin Laxity on Neck

United States
Galderma R&D

Completed

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis

United States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
Tris Pharma, Inc.
Forest Laboratories

Completed

Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain

Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

United States
Monash University
Turning Point

Completed

Brain Exercise and Addiction Trial (BEAT)

Cannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe

Australia
Cochlear
Avania; QbD Clinical

Recruiting

Comparing the Performance of a Categorical Loudness Scaling Based Fitting With a Behavioural Fitting in Adults With a Nucleus Cochlear Implant 3 Months Post-activation (CALOS4)

Hearing Loss

Germany, Australia, United States
AstraZeneca

Completed

Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. (ASCENT COPD)

Chronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPD

United States, Canada
Cochlear

Completed

Collection and Characterization of Objective Measures to Explore the Specificity of Algorithms

Hearing Loss

Spain, Australia, Germany
Cochlear, Asia Pacific
The HEARing Co-operative Research Centre, Melbourne; Melbourne Cochlear Implant... and other collaborators

Unknown

Evaluation of Performance and Usability of N6 in the Paediatric Population

Hearing Loss | Transplants and Implants

Australia, New Zealand
Vanderbilt University Medical Center
National Institute on Deafness and Other Communication Disorders (NIDCD)

Recruiting

Combined Electric and Acoustic Hearing (EAS) in Children and Adults

Hearing Loss | Cochlear Implant

United States
The University of Queensland
National Health and Medical Research Council, Australia

Completed

Health Intervention for Adolescents With Intellectual Disability (Ask)

Obesity | Hearing Impairment | Vision Impairment

Australia
Cochlear

Recruiting

Multi-center Study to Examine Changes to the Environment Surrounding the Electrodes in the Cochlea and to Capture the Most Challenging Listening Environments Experienced by Persons With a Cochlear Implant (DICE)

Hearing Loss

Belgium, Australia, Sweden
Nektar Therapeutics

Recruiting

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis (REZOLVE-AD)

Moderate to Severe Atopic Dermatitis

Spain, Czechia, United States, Australia, Croatia, Bulgaria, Poland, Canada, Germany, Hungary
Galderma R&D

Active, not recruiting

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis

United States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

United States, Australia, China, New Zealand
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

Moderate to Severe Persistent Asthma

United States, China, Hungary, Korea, Republic of, Poland
Nacuity Pharmaceuticals, Inc.
Foundation Fighting Blindness

Active, not recruiting

Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome (SLO RP)

Usher Syndromes

Australia

Clinical Trials on Moderate to Severe Hearing Loss in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations